← Back to Clinical Trials
Recruiting NCT07234552

NCT07234552 Impact of Abutment Screw Torque on Marginal Bone Loss

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07234552
Status Recruiting
Phase
Sponsor University of Valencia
Condition Soft Tissues According to the Abutment Torque
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-01-01
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Abutment torqued to 15 NcmPilar torqued to 30 Ncm2 mm healing cap

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-01-01 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this clinical trial is to evaluate the impact of different torque values applied during transmucosal abutment placement in dental implants on marginal bone loss and peri-implant parameters, including the patient's perception of the treatment. The main questions the study aims to answer are: 1. Is there any difference in marginal bone loss between abutments torqued at 15 Ncm, 30 Ncm, and submerged implants without immediate transmucosal connection? 2. Are there differences in microleakage between the different torque levels? 3. How do these torque values affect peri-implant soft tissues and patient satisfaction? 4. Does the applied torque influence the patient's quality of life after the prosthetic phase? Each participant will receive three dental implants during the same surgical procedure. One of the following approaches will be applied to each implant: 1. A transmucosal abutment torqued to 15 Ncm 2. A transmucosal abutment torqued to 30 Ncm 3. A healing cap without transmucosal connection (submerged implant) After implant placement, clinical and radiographic assessments will be performed to measure marginal bone loss and peri-implant parameters.

Eligibility Criteria

Inclusion Criteria: * Posterior edentulism * Completion of craniofacial growth * Full-mouth plaque index and bleeding index \< 25% * Sufficient bone height and width for implant placement without the need for bone regeneration procedures * Presence of at least 2 mm of keratinized mucosa around the dental implant * Stable occlusion and healthy periodontium * Absence of medical conditions that contraindicate implant surgery, such as heavy smoking (\<10 cigarettes per day), severe bruxism, pregnancy or breastfeeding, bisphosphonate therapy, and patients undergoing chemotherapy or radiotherapy in the head and/or neck area * Uncooperative patients Exclusion Criteria: * Loss to follow-up * Incorrectly parallelized periapical radiographs

Contact & Investigator

Central Contact

Juan Carlos Bernabeu Mira

✉ jcbernabeumira@gmail.com

📞 +34 697 348 312

Principal Investigator

Paula Claver Baldovi

PRINCIPAL INVESTIGATOR

University of Valencia

Frequently Asked Questions

Who can join the NCT07234552 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Soft Tissues According to the Abutment Torque. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07234552 currently recruiting?

Yes, NCT07234552 is actively recruiting participants. Contact the research team at jcbernabeumira@gmail.com for enrollment information.

Where is the NCT07234552 trial being conducted?

This trial is being conducted at Valencia, Spain.

Who is sponsoring the NCT07234552 clinical trial?

NCT07234552 is sponsored by University of Valencia. The principal investigator is Paula Claver Baldovi at University of Valencia. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology